Skip to main content

Table 5 Shift from baseline to end-point (LOCF) in SDQ scale properties

From: Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance

 

SDQ scale properties at baseline (bandings of raw scores)

SDQ scale properties at end-point (LOCF), n (%)

Low Need

Some Need

High Need

Total

Conduct problems

Low Need (0 to 3)

40 (76.9)

9 (17.3)

3 (5.8)

52 (100.0)

Some Need (4)

24 (51.1)

14 (29.8)

9 (19.1)

47 (100.0)

High Need (5 to 10)

44 (20.6)

39 (18.2)

131 (61.2)

214 (100.0)

Hyperactivity/inattention

Low Need (0 to 5)

78 (87.6)

5 (5.6)

6 (6.7)

89 (100.0)

Some Need (6)

18 (46.2)

13 (33.3)

8 (20.5)

39 (100.0)

High Need (7 to 10)

56 (29.8)

27 (14.4)

105 (55.9)

188 (100.0)

Emotional symptoms

Low Need (0 to 3)

99 (90.0)

4 (3.6)

7 (6.4)

110 (100.0)

Some Need (4)

20 (48.8)

9 (22.0)

12 (29.3)

41 (100.0)

High Need (5 to 10)

43 (25.7)

18 (10.8)

106 (63.5)

167 (100.0)

Peer problems

Low Need (0 to 3)

26 (68.4)

5 (13.2)

7 (18.4)

38 (100.0)

Some Need (4)

9 (18.4)

25 (51.0)

15 (30.6)

49 (100.0)

High Need (5 to 10)

22 (9.7)

26 (11.5)

179 (78.9)

227 (100.0)

Total difficulties score

Low Need (0 to 12)

20 (74.1)

3 (11.1)

4 (14.8)

27 (100.0)

Some Need (13 to 15)

14 (37.8)

16 (43.2)

7 (18.9)

37 (100.0)

High Need (16 to 40)

45 (18.4)

36 (14.7)

164 (66.9)

245 (100.0)

Prosocial behavior

Low Need (6 to 10)

62 (81.6)

8 (10.5)

6 (7.9)

76 (100.0)

Some Need (5)

19 (41.3)

18 (39.1)

9 (19.6)

46 (100.0)

High Need (0 to 4)

29 (14.9)

24 (12.4)

141 (72.7)

194 (100.0)